Navigation Links
ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.

CHARLOTTESVILLE, Va., Jan. 26, 2012 /PRNewswire/ -- ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced that it has signed an OEM agreement with Saudi Diagnostics Limited (SDL) for ZyGEM's DNA and RNA extraction kits.  SDL was established by the King Faisal Specialist Hospital & Research Centre (KFSH&RC) as part of the Saudi Arabian government's drive to develop a biotechnology sector in the Kingdom.  SDL specializes in the development of molecular genetic tests that are unique in their relevance to Arab populations.

"SDL is a pioneering institution dedicated to the development and provision of advanced biotechnology products and services in Saudi Arabia and the Middle East, and we are very pleased that they will be marketing our leading nucleic acid extraction products for a variety of research applications," said Paul Kinnon, CEO of ZyGEM.  "This OEM agreement is the most recent example of our ongoing strategy of partnering with innovative companies to bring the advantages of our accurate, fast and easy-to-use RNA and DNA extraction technologies to researchers worldwide."

ZyGEM's line of nucleic acid extraction kits feature optimized formulations of proprietary enzymatic technologies that use a single-tube process to provide complete extraction of high quality DNA or RNA from specific sample types rapidly and cost effectively.  ZyGEM's patented thermophilic enzymes have been isolated from the company's proprietary culture collection, consisting of rare microorganisms from extreme environments.

Established in 2007, SDL was the first company to offer molecular diagnostic tests in the Arabic Middle East that meet the rigorous College of American Pathologists (CAP) quality standards.  SDL is now serving as the commercial arm of KFSH&RC for developing and spinning-out new biotechnology companies.  KFSH&RC is Saudi Arabia's leading specialist hospital.  Its Research Centre is also the preeminent medical and biological research center in the region, with internationally renowned scientists and advanced research facilities. 

"At SDL, our commitment is to support the expansion of world-class biomedical research in Saudi Arabia and throughout the Middle East," commented Khalid S. A. Khabar, Ph.D., Director, Program in BioMolecular Research at KFSH&RC.  "Our relationship with ZyGEM, along with access to its leading DNA and RNA extraction technologies, will help SDL to rapidly develop and expand its product base and provide services at the cutting edge of science and technology."

Dr. Khabar continued, "For example, Al Bio is a recent KFSH&RC biotechnology start-up that will soon commence commercial operations, initially under SDL management.  Al Bio will provide regional research and medical institutions with a reliable local supply of key laboratory reagents at international quality standards, including kits incorporating ZyGEM's nucleic acid extraction technologies."

ZyGEM's proprietary technology significantly reduces the time and cost of DNA and RNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination, ensuring sample integrity and facilitating extractions from trace samples.  It is easily adaptable for use with off-the-shelf laboratory automation systems.  The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification.  ZyGEM's technology has been validated for use in highly regulated applications.

About ZyGEM
ZyGEM Corporation markets nucleic acid extraction solutions based on the company's exclusive collection of microorganisms from extreme environments, with applications in basic research, forensics, clinical diagnostics and agriculture.  ZyGEM's MicroLab unit is developing integrated sample-to-answer systems with the potential to revolutionize DNA testing.  For more information, visit Contacts:


Media:Paul Kinnon

GendeLLindheim BioCom PartnersPresident and CEO

Barbara Lindheim or Jennifer Anderson858 720-8333

212 584-2276 


Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
2. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
3. ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe
4. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
5. ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicons Research and Diagnostic Products
6. ZyGEM Releases Data Confirming its prepGEM(R) Insect Kit is a Simple, Rapid Method for Extracting Insect DNA for Species Identification
7. ZyGEM Strengthens its Worldwide Presence With New Distribution Agreement for Japan
8. Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM(R) Kit is a Reliable, Rapid Method for Extracting DNA From Saliva
9. ZyGEM Strengthens Senior Management Team With New Appointments
10. Application Note Shows ZyGEMs forensicGEM® Tissue Facilitates Forensic Casework by Rapidly and Reproducibly Extracting DNA From Human Hair
11. ZyGEM and USAMRIID Sign CRADA for Development of Simplified Sample Processing Solutions for Biothreat Agents
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... ... 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by its ... as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV ... embraced this type of racing and several new model aviation pilots have joined the ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
Breaking Biology Technology:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):